What did @adelemhealth actually say?
This is a straightforward endorsement video. @adelemhealth describes struggling to find a reputable peptide source, then landing on System Labs. Her core claims: the company has "a licensed clinician that provides oversight," sources compounds through "US licensed pharmacies," and delivers products that are actually what they claim to be. She frames this as a solution to peptides being "the wild west."
To be clear, she does not make specific therapeutic claims in this video. She does not say peptides cured her of anything or name a specific peptide protocol. The claims are about sourcing quality and company legitimacy, not pharmacology. That makes this easier to evaluate than most peptide content, but it also means the fact-check lives or dies on whether those company-level claims hold up.
Does the science back this up?
The concern she raises is legitimate. Peptide quality in the gray market is genuinely poor. Multiple independent analyses have found the problem is real, which is the one area where she gets full credit.
A 2021 study in JAMA (Cohen et al.) found that a significant share of peptide products sold online were mislabeled or contained incorrect concentrations. A 2023 analysis published in Drug Testing and Analysis found that peptides marketed as research chemicals frequently failed purity testing. The FDA has also issued multiple warning letters to compounding pharmacies over sterile preparation failures.
Her point that sourcing from US-licensed pharmacies improves safety relative to gray-market suppliers is directionally correct. State-licensed 503A compounding pharmacies operate under USP standards for sterility and potency. That is meaningfully different from a research chemical vendor with no oversight. The claim is not that compounded peptides are equivalent to FDA-approved drugs, it is that they clear a higher bar than unregulated alternatives, which is accurate.
What did they get wrong (or right)?
She got the foundational concern right: the peptide supply chain is genuinely chaotic. She is also correct that licensed clinician oversight and pharmacy-sourced compounds represent a higher standard than the typical online peptide vendor.
What she gets fuzzy on is the limits of that protection. "US licensed pharmacy" is not a single standard. There are 503A pharmacies that compound for individual patients with a valid prescription and 503B outsourcing facilities with broader manufacturing authority. Neither produces FDA-approved drugs. A licensed compounding pharmacy can still produce a subpotent batch. Oversight exists, but it is not a guarantee of perfection.
The bigger issue is verification. She says System Labs sources through US licensed pharmacies, but she cannot independently verify that claim herself, and neither can most consumers. She is taking the company at its word, which is understandable but worth naming. The transparency she praises is self-reported transparency. That is not the same as third-party audited transparency.
- Correct: Gray-market peptide quality is a documented, serious problem.
- Correct: Licensed pharmacy sourcing is a meaningful step up from research chemical vendors.
- Overstated: "Licensed pharmacy" does not guarantee product accuracy or clinical safety.
- Unverifiable: The specific claims about System Labs cannot be confirmed from public records alone.
What should you actually know?
If you are considering peptide therapy, the sourcing question matters enormously, and she is right to flag it. But here is what the video does not tell you: in the United States, most peptides discussed in this category, including BPC-157, TB-500, and CJC-1295, are not FDA-approved drugs. They exist in a regulatory gap. Compounding pharmacies can prepare them under certain conditions, but the FDA has taken action against some of these compounds, and the rules are shifting.
The most protective path is working with a licensed clinician who reviews your medical history, orders from a pharmacy they have a verified relationship with, and follows up on outcomes. That process is different from simply buying from a company that says it has clinician oversight. Ask specifically: is the clinician reviewing your individual case, or are they providing general oversight to the company? That distinction matters legally and clinically.
No peptide source, however reputable, makes a peptide therapeutic by itself. Efficacy still depends on the compound, the indication, and your individual biology, areas where the human evidence base is thin for most of these molecules.
Our bottom line
This video is one of the more responsible peptide endorsements circulating on TikTok right now, which is a low bar, but she clears it. The sourcing concerns she raises are real. The solution she describes, licensed clinician involvement and pharmacy-sourced compounds, is a genuine improvement over gray-market vendors. The gap in her argument is that she presents company self-reporting as verified trustworthiness. It is not. Do your own due diligence before putting any compounded peptide in your body, regardless of who recommended it.